1. Home
  2. ACHV vs TKNO Comparison

ACHV vs TKNO Comparison

Compare ACHV & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$5.79

Market Cap

239.0M

Sector

Health Care

ML Signal

HOLD

Logo Alpha Teknova Inc.

TKNO

Alpha Teknova Inc.

HOLD

Current Price

$3.39

Market Cap

214.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACHV
TKNO
Founded
N/A
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
239.0M
214.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ACHV
TKNO
Price
$5.79
$3.39
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$15.50
N/A
AVG Volume (30 Days)
660.3K
222.1K
Earning Date
11-06-2025
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$39,801,000.00
Revenue This Year
N/A
$8.79
Revenue Next Year
N/A
$10.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
9.50
52 Week Low
$1.84
$3.27
52 Week High
$6.03
$10.37

Technical Indicators

Market Signals
Indicator
ACHV
TKNO
Relative Strength Index (RSI) 69.73 27.71
Support Level $5.30 $3.85
Resistance Level $5.72 $4.19
Average True Range (ATR) 0.34 0.32
MACD 0.08 -0.04
Stochastic Oscillator 86.38 2.15

Price Performance

Historical Comparison
ACHV
TKNO

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

Share on Social Networks: